Endocan Corp Retained Earnings vs. Total Asset

ENDO Stock  USD 0.0001  0.00  0.00%   
Considering Endocan Corp's profitability and operating efficiency indicators, Endocan Corp may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Endocan Corp's ability to earn profits and add value for shareholders.
For Endocan Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Endocan Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Endocan Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Endocan Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Endocan Corp over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between Endocan Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Endocan Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Endocan Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Endocan Corp Total Asset vs. Retained Earnings Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Endocan Corp's current stock value. Our valuation model uses many indicators to compare Endocan Corp value to that of its competitors to determine the firm's financial worth.
Endocan Corp is rated # 3 in retained earnings category among its peers. It is rated # 2 in total asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Endocan Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Endocan Corp's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Endocan Total Asset vs. Retained Earnings

Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Endocan Corp

Retained Earnings

 = 

Beginning RE + Income

-

Dividends

 = 
(32.94 M)
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Endocan Corp

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
359
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Endocan Total Asset Comparison

Endocan Corp is currently under evaluation in total asset category among its peers.

Endocan Corp Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Endocan Corp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Endocan Corp will eventually generate negative long term returns. The profitability progress is the general direction of Endocan Corp's change in net profit over the period of time. It can combine multiple indicators of Endocan Corp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Thermic Sciences International develops and sells hemp based products. Thermic Sciences International was incorporated in 1969 and is based in Colorado Springs, Colorado. ENDOCAN CORP operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange.

Endocan Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Endocan Corp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Endocan Corp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Endocan Corp's important profitability drivers and their relationship over time.

Use Endocan Corp in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Endocan Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endocan Corp will appreciate offsetting losses from the drop in the long position's value.

Endocan Corp Pair Trading

Endocan Corp Pair Trading Analysis

The ability to find closely correlated positions to Endocan Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Endocan Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Endocan Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Endocan Corp to buy it.
The correlation of Endocan Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Endocan Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Endocan Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Endocan Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Endocan Corp position

In addition to having Endocan Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Losers Thematic Idea Now

Latest Losers
Latest Losers Theme
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Losers theme has 223 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Losers Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Endocan Pink Sheet

To fully project Endocan Corp's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Endocan Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Endocan Corp's income statement, its balance sheet, and the statement of cash flows.
Potential Endocan Corp investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Endocan Corp investors may work on each financial statement separately, they are all related. The changes in Endocan Corp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Endocan Corp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.